Intracoronary administration of levosimendan in cardiac surgery patients [Sepelvaltimoihin annetun levosimendaanin vaikutuksia sydänleikkauspotilailla].
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Levosimendan (Primary)
- Indications Left ventricular dysfunction
- Focus Therapeutic Use
- 21 Apr 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2011-002643-10).
- 13 Apr 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Jan 2012 New trial record